Silexion Therapeutics Corp (SLXN): Next-Year EPS Estimate 45.87%
As of 2026-06-04, Silexion Therapeutics Corp (SLXN) has a next-year EPS growth estimate of 45.87%.
Analyst estimates for SLXN have remained steady in the most recent observable window, with next-year EPS growth projected at 45.87%. Current-year growth stands at 54.02%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 45.87%
- EPS growth this year
- 54.02%
- EPS next quarter (est)
- -$13.10
- Last price
- $4.96
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 45.87% | 54.02% | -$13.10 | $4.96 |
| 2026-06-03 | 45.87% | 54.02% | -$13.10 | $4.86 |
| 2026-06-02 | 45.87% | 54.02% | -$13.10 | $4.99 |
| 2026-05-28 | 45.87% | 54.02% | -$1.31 | $0.43 |
| 2026-05-27 | 45.87% | 54.02% | -$1.31 | $0.42 |
| 2026-05-26 | 45.87% | 54.02% | -$1.31 | $0.43 |
| 2026-05-25 | 45.87% | 54.02% | -$1.31 | $0.50 |
| 2026-05-24 | 45.87% | 54.02% | -$1.31 | $0.50 |
| 2026-05-21 | 45.87% | 54.02% | -$1.31 | $0.47 |
| 2026-05-20 | 45.87% | 54.02% | -$1.31 | $0.53 |
| 2026-05-19 | 45.87% | 54.02% | -$1.31 | $0.27 |
| 2026-05-18 | 45.87% | 54.02% | -$1.31 | $0.27 |
| 2026-05-17 | 45.87% | 54.02% | -$1.29 | $0.29 |
| 2026-05-14 | 45.87% | 54.02% | -$1.29 | $0.50 |
| 2026-05-13 | 45.87% | 54.02% | -$1.29 | $0.53 |
| 2026-05-12 | 45.87% | 54.02% | -$1.29 | $0.58 |
| 2026-05-11 | 45.87% | 54.02% | -$1.29 | $0.51 |
| 2026-05-10 | 45.87% | 54.02% | -$1.29 | $0.52 |
| 2026-05-07 | 45.87% | 54.02% | -$1.29 | $0.52 |
| 2026-05-06 | 45.87% | 54.02% | -$1.29 | $0.57 |
| 2026-05-05 | 45.87% | 54.02% | -$1.29 | $0.60 |
| 2026-05-04 | 45.87% | 54.02% | -$1.29 | $0.63 |
| 2026-05-03 | 45.87% | 54.02% | -$1.29 | $0.60 |
| 2026-04-30 | 45.87% | 54.02% | -$1.29 | $0.61 |
| 2026-04-29 | 45.87% | 54.02% | -$1.29 | $0.63 |
| 2026-04-28 | 45.87% | 54.02% | -$1.29 | $0.64 |
| 2026-04-27 | 45.87% | 54.02% | -$1.29 | $0.73 |
| 2026-04-26 | 45.87% | 54.02% | -$1.29 | $0.78 |
| 2026-04-24 | 45.87% | 54.02% | -$1.29 | $0.78 |
| 2026-04-23 | 45.87% | 54.02% | -$1.29 | $0.92 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Silexion Therapeutics Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Silexion Therapeutics Corp (SLXN) has a next-year EPS growth estimate of 45.87%, based on analyst consensus.
What sector and industry does Silexion Therapeutics Corp belong to?▾
Silexion Therapeutics Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SLXN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Silexion Therapeutics Corp (SLXN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports